Article
Activin-inhibitory action on lactotrophs is decreased in lactotroph hyperplasia.
The Journal of endocrinology - 1 Feb 2020
Faraoni E Y, Abeledo Machado A I, Pérez P A, Marcial López C A, Camilletti M A, Peña-Zanoni M, Rulli S B, Gutiérrez S, Díaz-Torga G
Abstract excerpt
Among all the hormone-secreting pituitary tumours, prolactinomas are the most frequently found in the clinic. Since dopamine is the primary inhibitor of lactotroph function, dopamine agonists represent the first-line therapy. However, a subset of patients exhibits resistance to these drugs, and therefore, alternative treatments are desired. As activins inhibit prolactin gene expression through the inhibition of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
